Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography.

Gupta P, Wentland JA, Leal M, Ma D, Roach R, Esparza A, King L, Spilker ME, Bagi C, Winkelmann CT, Giddabasappa A.

Oncotarget. 2017 Jul 26;8(34):57231-57245. doi: 10.18632/oncotarget.19569. eCollection 2017 Aug 22.

2.

Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.

Chen Y, Zhang S, Wang Q, Zhang X.

J Hematol Oncol. 2017 Feb 1;10(1):36. doi: 10.1186/s13045-017-0408-0.

3.

Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression.

Huang C, Li N, Li Z, Chang A, Chen Y, Zhao T, Li Y, Wang X, Zhang W, Wang Z, Luo L, Shi J, Yang S, Ren H, Hao J.

Nat Commun. 2017 Jan 19;8:14035. doi: 10.1038/ncomms14035.

4.

AllergoOncology - the impact of allergy in oncology: EAACI position paper.

Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M, Dombrowicz D, Daniels-Wells TR, Fazekas J, Fiebiger E, Gatault S, Gould HJ, Janda J, Josephs DH, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova D, Mekori Y, Mungenast F, Nigro EA, Penichet ML, Redegeld F, Saul L, Singer J, Spicer JF, Siccardi AG, Spillner E, Turner MC, Untersmayr E, Vangelista L, Karagiannis SN.

Allergy. 2017 Jun;72(6):866-887. doi: 10.1111/all.13119. Epub 2017 Jan 23.

PMID:
28032353
5.

ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.

Zhao T, Jiang W, Wang X, Wang H, Zheng C, Li Y, Sun Y, Huang C, Han ZB, Yang S, Jia Z, Xie K, Ren H, Hao J.

Cancer Res. 2017 Feb 15;77(4):874-885. doi: 10.1158/0008-5472.CAN-16-2170. Epub 2016 Dec 6.

PMID:
27923832
6.

IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.

Cao H, Zhang J, Liu H, Wan L, Zhang H, Huang Q, Xu E, Lai M.

Oncotarget. 2016 Sep 20;7(38):61183-61198. doi: 10.18632/oncotarget.11282.

7.

The Growth Inhibitory Potential and Antimetastatic Effect of Camel Urine on Breast Cancer Cells In Vitro and In Vivo.

Romli F, Abu N, Khorshid FA, Syed Najmuddin SUF, Keong YS, Mohamad NE, Hamid M, Alitheen NB, Nik Abd Rahman NMA.

Integr Cancer Ther. 2017 Dec;16(4):540-555. doi: 10.1177/1534735416656051. Epub 2016 Jun 23.

8.

IL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.

Jiang L, Cheng Q, Zhang B, Zhang M.

Am J Transl Res. 2016 Feb 15;8(2):1064-72. eCollection 2016.

9.

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.

Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI.

Breast Cancer Res. 2015 Jul 25;17:98. doi: 10.1186/s13058-015-0607-y.

10.

The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.

Maione F, Oliaro-Bosso S, Meda C, Di Nicolantonio F, Bussolino F, Balliano G, Viola F, Giraudo E.

Sci Rep. 2015 Mar 12;5:9054. doi: 10.1038/srep09054.

11.

LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.

Zhao T, Ren H, Li J, Chen J, Zhang H, Xin W, Sun Y, Sun L, Yang Y, Sun J, Wang X, Gao S, Huang C, Zhang H, Yang S, Hao J.

Cancer Res. 2015 Jan 1;75(1):111-9. doi: 10.1158/0008-5472.CAN-14-2040. Epub 2014 Nov 10.

12.

Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.

Sánchez-Reyes K, Bravo-Cuellar A, Hernández-Flores G, Lerma-Díaz JM, Jave-Suárez LF, Gómez-Lomelí P, de Celis R, Aguilar-Lemarroy A, Domínguez-Rodríguez JR, Ortiz-Lazareno PC.

Biomed Res Int. 2014;2014:683068. doi: 10.1155/2014/683068. Epub 2014 Sep 21.

13.

Cellular immunotherapy for pediatric solid tumors.

Hegde M, Moll AJ, Byrd TT, Louis CU, Ahmed N.

Cytotherapy. 2015 Jan;17(1):3-17. doi: 10.1016/j.jcyt.2014.05.019. Epub 2014 Jul 28. Review.

14.

IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.

Zhao Z, Wang L, Xu W.

Oncogene. 2015 Mar 19;34(12):1596-607. doi: 10.1038/onc.2014.53. Epub 2014 Apr 21.

15.

Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.

Thaci B, Brown CE, Binello E, Werbaneth K, Sampath P, Sengupta S.

Neuro Oncol. 2014 Oct;16(10):1304-12. doi: 10.1093/neuonc/nou045. Epub 2014 Apr 10. Review.

16.

Early onset pancreatic cancer: a controlled trial.

Tingstedt B, Weitkämper C, Andersson R.

Ann Gastroenterol. 2011;24(3):206-212.

17.

Autoimmunity as a double agent in tumor killing and cancer promotion.

Toomer KH, Chen Z.

Front Immunol. 2014 Mar 18;5:116. doi: 10.3389/fimmu.2014.00116. eCollection 2014. Review.

18.

Interleukin-13 and its receptors in colorectal cancer (Review).

Zhou R, Qian S, Gu X, Chen Z, Xiang J.

Biomed Rep. 2013 Sep;1(5):687-690. Epub 2013 Jul 11.

19.

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.

Hall B, Nakashima H, Sun ZJ, Sato Y, Bian Y, Husain SR, Puri RK, Kulkarni AB.

J Transl Med. 2013 Feb 19;11:45. doi: 10.1186/1479-5876-11-45.

20.

Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.

Hallett MA, Venmar KT, Fingleton B.

Cancer Res. 2012 Dec 15;72(24):6338-43. doi: 10.1158/0008-5472.CAN-12-3544. Epub 2012 Dec 7. Review.

Supplemental Content

Support Center